Back to Search Start Over

COVID-19--Associated Hospitalizations Among U.S. Adults Aged ≥65 Years -- COVID-NET, 13 States, January--August 2023.

Authors :
Taylor, Christopher A.
Patel, Kadam
Patton, Monica E.
Reingold, Arthur
Kawasaki, Breanna
Meek, James
Openo, Kyle
Ryan, Patricia A.
Falkowski, Anna
Bye, Erica
Plymesser, Kelly
Spina, Nancy
Tesini, Brenda L.
Moran, Nancy E.
Sutton, Melissa
Talbot, H. Keipp
George, Andrea
Havers, Fiona P.
Source :
MMWR: Morbidity & Mortality Weekly Report; 10/6/2023, Vol. 72 Issue 40, p1089-1094, 6p
Publication Year :
2023

Abstract

Adults aged ≥65 years remain at elevated risk for severe COVID-19 disease and have higher COVID-19--associated hospitalization rates compared with those in younger age groups. Data from the COVID-19--Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to estimate COVID-19--associated hospitalization rates during January-- August 2023 and identify demographic and clinical characteristics of hospitalized patients aged ≥65 years during January--June 2023. Among adults aged ≥65 years, hospitalization rates more than doubled, from 6.8 per 100,000 during the week ending July 15 to 16.4 per 100,000 during the week ending August 26, 2023. Across all age groups, adults aged ≥65 years accounted for 62.9% (95% CI = 60.1%--65.7%) of COVID-19--associated hospitalizations, 61.3% (95% CI = 54.7%--67.6%) of intensive care unit admissions, and 87.9% (95% CI = 80.5%--93.2%) of in-hospital deaths associated with COVID-19 hospitalizations. Most hospitalized adults aged ≥65 years (90.3%; 95% CI = 87.2%--92.8%) had multiple underlying conditions, and fewer than one quarter (23.5%; 95% CI = 19.5%--27.7%) had received the recommended COVID-19 bivalent vaccine. Because adults aged ≥65 years remain at increased risk for COVID-19--associated hospitalization and severe outcomes, guidance for this age group should continue to focus on measures to prevent SARS-CoV-2 infection, encourage vaccination, and promote early treatment for persons who receive a positive SARS-CoV-2 test result to reduce their risk for severe COVID-19--associated outcomes. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01492195
Volume :
72
Issue :
40
Database :
Complementary Index
Journal :
MMWR: Morbidity & Mortality Weekly Report
Publication Type :
Academic Journal
Accession number :
172795067
Full Text :
https://doi.org/10.15585/mmwr.mm7240a3